English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    S. A. Guliuk, S. A. Shnaider, O. V. Dienha, D. O. Yakimenko, S. V. Rachynskyi, O. A. Pryima, N. O. Blazhkiv

    GENETIC PREDISPOSITION TO THE RISK OF POTENTIALLY MALIGNANT AND MALIGNANT HEAD AND NECK DISEASES, TP53, TLR2, DEFB1 GENE POLYMORPHISM


    About the author: S. A. Guliuk, S. A. Shnaider, O. V. Dienha, D. O. Yakimenko, S. V. Rachynskyi, O. A. Pryima, N. O. Blazhkiv
    Heading CLINICAL MEDICINE
    Type of article Scentific article
    Annotation The study was devoted to the identifying associations between leukoplakia, head-and-neck carcinogenesis and single-nucleotide polymorphisms in three genes: the tumour-suppressor TP53 Arg72Pro (rs1042522), the cell-surface receptor TLR2 Arg753Gln (rs5743708) and the antimicrobial peptide gene DEFB1 G-20A (rs11362). The study involved 60 patients aged 25–55 years with leukoplakia (n=20), oncology (n=20) and control (n=20). Allelic variants of the genes were genotyped by allele-specific polymerase chain reaction. A genetic predisposition to diseases affecting the oral mucosa has been demonstrated for both the development of leukoplakia and the emergence of malignancies. A statistically significant association was observed between the rs1042522 TP53 Arg72Pro polymorphism, the rs11362 DEFB1 G-20A polymorphism and the risk of oral pathologies. Insight into these risk factors, coupled with early diagnostic screening, may enable individuals to adopt preventive measures that lower their probability of developing such conditions.
    Tags DNA methylation,oral cancer,premalignant lesions,biomarkers,early diagnosis
    Bibliography
    • Rohach IM, Keretsman AO, Sitkar AD. Pravylno vybranyy metod statystychnoho analizu – shlyakh do yakisnoyi interpretatsiyi danykh medychnykh doslidzhen. Naukovyy visnyk Uzhhorodskoho universytetu, seriya “Medytsyna”. 2017;2(56):124–128. [in  Ukrainian].
    • Bewley AF, Farwell DG. Oral leukoplakia and oral squamous cell carcinoma. Clin Dermatol. 2017;35:461–467. DOI:  10.1016/j.clindermatol.2017.06.008.
    • Bhardwaj A, Prasad D, Mukherjee S. Role of toll-like receptor in the pathogenesis of oral cancer. Cell Biochem Biophys. 2024;82(1):91–105. DOI: 10.1007/s12013-023-01191-8.
    • Bray F, Ferley J, Sorjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality from 36 cancers worldwide in 185 countries. CA Cancer J Clin. 2018;68:394–424. DOI:  10.3322/CAAC.21492.
    • Carrard WC, van der Waal I. Clinical diagnosis of oral leukoplakia: a guide for dentists. Med Oral Patol Oral Cir Bucal. 2017;23:e59–e64. DOI: 10.4317/medoral.22292.
    • Chaturvedi AK, Udaltsova N, Engels EA, Katzel JA, Yanik EL, Katki HA, Lingen MW, Silverberg MJ. Oral leukoplakia and risk of progression to oral cancer: a population-based cohort study. J Natl Cancer Inst. 2020;112(10):1047–1054. DOI:  10.1093/jnci/djz238.
    • Janik EL, Katki HA, Silverberg MJ, Manos MM, Engels EA, Chaturvedi AK. Leukoplakia, oral cancer risk, and cancer survival in older adults in the United States. Cancer Prev Res. 2015;8(9):857–863.
    • Onda T, Hayashi K, Katakura A, Takano M. Oral leukoplakia and oral cancer. Cleve Clin J Med. 2023;90(2):79–80. DOI:  10.3949/ccjm.90a.22044. 2
    • Pisani LP, Estadella D, Ribeiro DA. The role of toll-like receptors (TLRs) in oral carcinogenesis. Anticancer Res. 2017;37(10):5389–5394. DOI: 10.21873/anticanres.11965.
    • Shield KD, Ferlay J, Jemal A, Sankaranarayanan R, Chaturvedi AK, Bray F, et al. Global incidence of cancer of the lip, oral cavity, and pharynx by subsite in 2012. CA Cancer J Clin. 2017;67(1):51–64.
    • Tiwari A, Chouhan AK. Antimicrobial peptides and their role in head and neck cancer. In: Baindara P, Mandal SM, editors. Evolution of antimicrobial peptides. Cham: Springer; 2024. p. [chapter 12]. DOI: 10.1007/978-3-031-67515-7_12.
    • Walsh PS, Metzger DA, Higuchi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques. 2013;54(3):134–139.
    • Warnakulasuriya S, Ariyawardana AV. Malignant transformation of oral leukoplakia: a systematic review of observational studies. J Oral Pathol Med. 2016;45(3):155–166
    • Zarate AM, Don J, Secchi D, et al. Study of the TP53 codon 72 polymorphism in oral cancer and oral potentially malignant disorders in Argentine patients. Tumour Biol. 2017;39(5):1010428317699113. DOI: 10.1177/1010428317699113.
    • Zhong S, Wang K, Gao R, Shu S, Shu K. Association between DEFB1 polymorphisms and periodontitis: a meta-analysis. Pharmazie. 2019;74(7):390–396.
    Publication of the article «World of Medicine and Biology» №2(92), 2025 year, 053-057 pages, index UDK 575.1:[616-006.6+611.31]
    DOI 10.26724/2079-8334-2025-2-92-53-57